biotech

Top HIV Vaccine Research Myths Busted

Filed in archive Uncategorized on April 30, 2013

Top HIV Vaccine Research Myths Busted
© avlxyz
Since World Aids Day is almost here, December 1st, the HIV Vaccine Trials Network which is headquartered at Fred Hutchinson Cancer Research Center clarifies the most common myths about HIV vaccine research. A very prevalant myth is that HIV vaccines can give people AIDS - this is not true. The HIV vaccine does not contain the HIV virus and hence cannot give patients the disease. Another top myth is that there already exists an HIV vaccine, but there is no licensed vaccine against AIDS or HIV. In 2009, a study conducted in Thailand called RV144 showed that a vaccine combination could prevent about 32 percent of new infections, scientists are working on improving this combination. Many people believe that if they are not infected with HIV, they do not need the vaccine. Prevention is always better than cure - need more be said.



comment!
(0)
vote!
(6.5/10)
e-mail!
Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
 img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
 img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

Biotech Hemophilia Drug

Filed in archive Corporate and Industrial News on April 25, 2013

Biotech Hemophilia Drug
© erix!
Biotech company Prolor has reported positive pre clinical trial results for its hemophilia drug known a Factor Vlla. The modified drug boasts a longer duration and half life of clotting activity versus current versions.

The animal trials of Factor Vlla were conducted in hemophilic mice, and compared side by side with current versions of recombinant Factor Vlla. The advanced Factor Vlla-CTP showed significantly improved results as compared to the current commercial version of the drug, which is used to treat acute bleeding in hemophiliacs and to prevent bleeding in patients with hemophilia A and B in which treatment with Factor IX or Factor VIII is ineffective. The results were consistent with pre clinical trials and are considered to be positive by the company. They expect Factor VIIa to be highly competitive in the $2 billion market for hemophilia treatments.

comment!
(0)
vote!
(8.0/10)
e-mail!
Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
 img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
 img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

China Pharma Partnerships

Filed in archive Misc on April 16, 2013

China Pharma Partnerships
© yummyporky
BeiGene is a Beijing-based biotech startup that focuses on oncology drugs. The company has attracted a large investment from pharma giant Merck, along with an agreement that should allow BeiGene to raise money from other pharmas and investors as well.

Pfizer is also active in the China market, committing to purchase a $50 million stake in Shanghai Pharmaceutical's upcoming Hong Kong IPO. Pfizer is one of four companies to participate in the offering which is expected to raise up to $2.2 billion. Sinocom Pharmaceutical, a distributor of pharma products to third and fourth tier cities in Central-Eastern China, will also IPO on Nasdaq Global Market exchange. The company will offer 15.8 million shares, and hopes to raise as much as $57.5 million in the offering. California oncology company Crown BioScience has labs in Beijing and Taicang City. It has raised $28.2 million to expand services in its core cancer drug discovery operations.

comment!
(0)
vote!
(7.7/10)
e-mail!
Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
 img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
 img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells